Advancing Biologics Through Integrated Research, Development, and Manufacturing
CuriRx, Inc. is a Contract Research, Development, and Manufacturing Organization (CRDMO) that provides end-to-end services for the production of toxicology batches.
An ISO 9001– and EcoVadis-certified, minority woman–owned company based in Wilmington, Massachusetts, CuriRx brings extensive expertise across biologics and drug development.
The company’s team of experienced scientists has a proven track record in supporting the development of commercial products such as Humira and Synagis (mAbs), Blincyto (bispecific antibody), and Gattex (peptide therapeutic).
